Sökning: id:"swepub:oai:DiVA.org:uu-191240" >
Morphological and f...
Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up : a patient level insight into the ABSORB A clinical trial
-
- Sarno, Giovanna (författare)
- Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
-
Bruining, Nico (författare)
-
Onuma, Yoshinobu (författare)
-
visa fler...
-
Garg, Scot (författare)
-
Brugaletta, Salvatore (författare)
-
De Winter, Sebastiaan (författare)
-
Regar, Evelyn (författare)
-
Thuesen, Leif (författare)
-
Dudek, Dariusz (författare)
-
Veldhof, Susan (författare)
-
Dorange, Cecile (författare)
-
Garcia-Garcia, Hector M (författare)
-
Ormiston, John A (författare)
-
Serruys, Patrick W (författare)
-
visa färre...
-
(creator_code:org_t)
- 2011-01-07
- 2012
- Engelska.
-
Ingår i: The international journal of cardiovascular imaging. - : Springer Science and Business Media LLC. - 1875-8312 .- 1569-5794 .- 1573-0743. ; 28:1, s. 51-58
- Relaterad länk:
-
https://repub.eur.nl...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The aim of this study was to describe vaso-reactivity (by Acetylcholine and Methergine tests) at 2 year follow-up in parallel with the individual changes in the echogenicity characteristics of the polymer struts of the everolimus eluting bioresorbable vascular scaffold (BVS), from post-treatment to 2 year follow-up, in patients enrolled in the ABSORB Cohort A study. Intravascular ultrasound assessment was performed with a phased array catheter (EagleEye, Volcano Corporation, Cordova, CA, USA) with automated pullback at 0.5 mm per second. The % ratio at 6 months and 2 years [(Scaffold Area post PCI- Lumen Area)/Scaffold Area post PCI] was calculated as a measure of scaffold shrinkage. The % change of hyperechogenicity was defined as: ([post-procedural hyperechogenicity] - [2 year follow up hyperechogenicity])/[post-procedural hyperechogenicity]) × 100. The vasomotion test with intracoronary acetylcholine (10(-6) M) or intravenous methergine (0.4 mg) was performed at 2 years. Overall nine patients received all these analyses and were enrolled in the present analysis. A 50-96% reduction in hyperechogenicity was observed between baseline and 2 years, which corresponded to a change in vasoreactivity between 2 and 22%. A vasoconstriction of the scaffolded segment was observed in the 5 patients, who underwent the methergine test, with a mean decrease in lumen diameter after methergine of 9 ± 7% (P = 0.06), while vasodilatation occurred in the 4 patients who underwent the acetylcholine test with a mean increase in lumen diameter after acetylcholine of 8 ± 5% (P = 0.125). Bioresorption of the BVS is accompanied by re-establishment of both endothelial and non-endothelial dependent vasomotion.
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Sarno, Giovanna
-
Bruining, Nico
-
Onuma, Yoshinobu
-
Garg, Scot
-
Brugaletta, Salv ...
-
De Winter, Sebas ...
-
visa fler...
-
Regar, Evelyn
-
Thuesen, Leif
-
Dudek, Dariusz
-
Veldhof, Susan
-
Dorange, Cecile
-
Garcia-Garcia, H ...
-
Ormiston, John A
-
Serruys, Patrick ...
-
visa färre...
- Artiklar i publikationen
-
The internationa ...
- Av lärosätet
-
Uppsala universitet